HCM
MEDS

Heights Capital Management’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Heights Capital Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,342
Closed -$2.59M – 229
2025
Q3 		$2.59M Buy
+58,342
New +$3.08M 0.74% 29

Other funds holding MEDS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return

Heights Capital Management's MEDS Position: Q4 2025 in Review

Heights Capital Management sold out of DataMeds AI, Inc. Common Stock (MEDS) in Q4 2025, closing a stake of 58,342 shares — an estimated $2.59M sold.

Heights Capital Management first reported a position in MEDS in Q3 2025 and held it in 1 quarter. The position peaked at $2.59M in Q3 2025. 19 funds tracked by Wall St. Rank hold MEDS as of Q4 2025.

  • Heights Capital Management reported no remaining DataMeds AI, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • Heights Capital Management sold 58,342 DataMeds AI, Inc. Common Stock shares in Q4 2025, an estimated $2.59M.
  • Heights Capital Management first reported a position in DataMeds AI, Inc. Common Stock in Q3 2025 and held it in 1 quarter.
  • Heights Capital Management's DataMeds AI, Inc. Common Stock position peaked at $2.59M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q4 2025.

Based on Heights Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.